Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfonso Pozzan

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Current Pharmaceutical Design|June 27, 2006
Molecular descriptors and methods for ligand based virtual high throughput screening in drug discoveryAlfonso Pozzan
Methods in Molecular Biology (Clifton, N.J.)|February 5, 2020
QM Calculations in ADMET PredictionAlfonso Pozzan
Methods in Molecular Biology (Clifton, N.J.)|November 3, 2021
Deep Learning Applied to Ligand-Based De Novo Drug DesignFerruccio Palazzesi, Alfonso Pozzan
Journal of Chemical Information and Modeling|March 28, 2006
Generation of a focused set of GSK compounds biased toward ligand-gated ion-channel ligandsAnna Maria Capelli, Aldo Feriani, Giovanna Tedesco, et al.
Bioorganic & Medicinal Chemistry Letters|October 12, 2010
2-Methyl-3-furanyl-4H-1,2,4-triazol-3-ylthioamides: a new class of selective orexin 2 antagonistsFabrizio Micheli, Marinella Antolini, Romano Di Fabio, et al.
Organic Letters|January 29, 2015
Stereoselective synthesis of 3-substituted tetrahydropyrazinoisoquinolines via intramolecular cyclization of enantiomerically enriched dihydro-2H-pyrazinesGianna Reginato, Maria Pia Catalani, Bernardo Pezzati, et al.
Bioorganic & Medicinal Chemistry Letters|August 8, 2007
A novel ketolide class: Synthesis and antibacterial activity of a lead compoundDaniele Andreotti, Ilaria Bientinesi, Stefano Biondi, et al.
Journal of Medicinal Chemistry|June 19, 2026
Applying Deep-Learning-Driven <i>De Novo</i> Design to Hit Identification: A Case Study on A<sub>2A</sub> Adenosine Receptor AntagonistsMargherita Persico, Alessandra Micoli, Veronica Salmaso, et al.
Bioorganic & Medicinal Chemistry Letters|August 3, 2010
Pyrrolo[1,2-a]pyrazine and pyrazolo[1,5-a]pyrazine: novel, potent, and selective series of Vasopressin 1b receptor antagonistsRoberto Arban, Federica Bianchi, Alberto Buson, et al.
Bioorganic & Medicinal Chemistry Letters|July 19, 2011
Identification of 2-(4-pyridyl)thienopyridinones as GSK-3β inhibitorsGabriella Gentile, Giovanni Bernasconi, Alfonso Pozzan, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Current Pharmaceutical Design|June 27, 2006
Molecular descriptors and methods for ligand based virtual high throughput screening in drug discoveryAlfonso Pozzan
Methods in Molecular Biology (Clifton, N.J.)|February 5, 2020
QM Calculations in ADMET PredictionAlfonso Pozzan
Methods in Molecular Biology (Clifton, N.J.)|November 3, 2021
Deep Learning Applied to Ligand-Based De Novo Drug DesignFerruccio Palazzesi, Alfonso Pozzan
Journal of Chemical Information and Modeling|March 28, 2006
Generation of a focused set of GSK compounds biased toward ligand-gated ion-channel ligandsAnna Maria Capelli, Aldo Feriani, Giovanna Tedesco, et al.
Bioorganic & Medicinal Chemistry Letters|October 12, 2010
2-Methyl-3-furanyl-4H-1,2,4-triazol-3-ylthioamides: a new class of selective orexin 2 antagonistsFabrizio Micheli, Marinella Antolini, Romano Di Fabio, et al.
Organic Letters|January 29, 2015
Stereoselective synthesis of 3-substituted tetrahydropyrazinoisoquinolines via intramolecular cyclization of enantiomerically enriched dihydro-2H-pyrazinesGianna Reginato, Maria Pia Catalani, Bernardo Pezzati, et al.
Bioorganic & Medicinal Chemistry Letters|August 8, 2007
A novel ketolide class: Synthesis and antibacterial activity of a lead compoundDaniele Andreotti, Ilaria Bientinesi, Stefano Biondi, et al.
Journal of Medicinal Chemistry|June 19, 2026
Applying Deep-Learning-Driven <i>De Novo</i> Design to Hit Identification: A Case Study on A<sub>2A</sub> Adenosine Receptor AntagonistsMargherita Persico, Alessandra Micoli, Veronica Salmaso, et al.
Bioorganic & Medicinal Chemistry Letters|August 3, 2010
Pyrrolo[1,2-a]pyrazine and pyrazolo[1,5-a]pyrazine: novel, potent, and selective series of Vasopressin 1b receptor antagonistsRoberto Arban, Federica Bianchi, Alberto Buson, et al.
Bioorganic & Medicinal Chemistry Letters|July 19, 2011
Identification of 2-(4-pyridyl)thienopyridinones as GSK-3β inhibitorsGabriella Gentile, Giovanni Bernasconi, Alfonso Pozzan, et al.
Pageof 2